Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/35625
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVEIRA-FILHO, Aldemir B.
dc.contributor.authorAIRES, Diego Wendel F.
dc.contributor.authorCAVALCANTE, Natalia S.
dc.contributor.authorRAIOL, Nairis Costa
dc.contributor.authorLISBOA, Brenda Luena A.
dc.contributor.authorFRADE, Paula Cristina R.
dc.contributor.authorCOSTA, Luana M. da
dc.contributor.authorPINHEIRO, Luiz Marcelo L.
dc.contributor.authorMACHADO, Luiz Fernando A.
dc.contributor.authorMARTINS, Luisa C.
dc.contributor.authorSILVA-OLIVEIRA, Glaucia C.
dc.contributor.authorPINHO, Joao Renato R.
dc.contributor.authorKUPEK, Emil
dc.contributor.authorLEMOS, Jose Alexandre R.
dc.date.accessioned2020-03-24T14:54:45Z-
dc.date.available2020-03-24T14:54:45Z-
dc.date.issued2019
dc.identifier.citationPATHOGENS, v.8, n.4, article ID 236, 14p, 2019
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35625-
dc.description.abstractBackground: Previous studies found a high prevalence of pathogens among female sex workers (FSWs) in the Amazon region, and established their parenteral and sexual transmission. This study estimated the prevalence of hepatitis C virus (HCV) infection and associated risk factors, and the frequency of HCV genotypes and resistance-associated substitutions (RASs) in this vulnerable group. Methods: Distinct sampling methods were used to access 412 FSWs in cities and riverside communities in the Amazon region from 2015 to 2018. Three methods for HCV diagnosis were used to determine infection status. HCV genotypes and RASs were identified by sequencing and nucleotide fragment analysis. An association between HCV infection and exposure factors was determined by bivariate and multivariate analysis. Results: In total, 44 (10.7%) FSWs were exposed to HCV, and 32 (7.8%) of them had active infection. Nine socioeconomic characteristics and risky sexual behaviors were associated with HCV exposure, particularly unprotected sex and condom exemption for the clients who paid extra money. Genotype 1 (81.3%) and 3 (18.7%) were detected. The frequency of FSWs with RASs was 23.1% (6/26) for grazoprevir related to the occurrence of substitutions Y56F and S122G. Conclusions: HCV infection among FSWs is highly prevalent and dominated by genotype I. Urgent preventive and treatment measures are required to reduce HCV infection in FSWs and the general population.eng
dc.description.sponsorshipFundacao Amazonia de Amparo a Estudos e Pesquisa (FAPESPA)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [ICAAF 154/2014]
dc.language.isoeng
dc.publisherMDPIeng
dc.relation.ispartofPathogens
dc.rightsopenAccesseng
dc.subjectepidemiologyeng
dc.subjectHCVeng
dc.subjectgenotypeeng
dc.subjectrisk factorseng
dc.subjectprotease inhibitorseng
dc.subjectfemale sex workerseng
dc.subjectwomen's healtheng
dc.subjectsocial vulnerabilityeng
dc.subjectamazon regioneng
dc.subject.othersexually-transmitted infectionseng
dc.subject.otherprotease inhibitor boceprevireng
dc.subject.otherillicit drug-userseng
dc.subject.otherresistance mutationseng
dc.subject.otherglobal epidemiologyeng
dc.subject.othermolecular evidenceeng
dc.subject.otherhcv infectioneng
dc.subject.otherblood-donorseng
dc.subject.otherprevalenceeng
dc.subject.othertransmissioneng
dc.titleHepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Regioneng
dc.typearticleeng
dc.rights.holderCopyright MDPIeng
dc.identifier.doi10.3390/pathogens8040236
dc.identifier.pmid31739623
dc.subject.wosMicrobiologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalOLIVEIRA-FILHO, Aldemir B.:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil; Univ Fed Santa Catarina, Programa Posgrad Saude Colet, BR-88040900 Florianopolis, SC, Brazil
hcfmusp.author.externalAIRES, Diego Wendel F.:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil
hcfmusp.author.externalCAVALCANTE, Natalia S.:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil
hcfmusp.author.externalRAIOL, Nairis Costa:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil
hcfmusp.author.externalLISBOA, Brenda Luena A.:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil
hcfmusp.author.externalFRADE, Paula Cristina R.:Univ Fed Para, Nucleo Med Trop, BR-66055240 Belem, PA, Brazil
hcfmusp.author.externalCOSTA, Luana M. da:Univ Fed Para, Nucleo Med Trop, BR-66055240 Belem, PA, Brazil
hcfmusp.author.externalPINHEIRO, Luiz Marcelo L.:Univ Fed Para, Fac Ciencias Biol, Campus Marajo, BR-68870000 Soure, PA, Brazil
hcfmusp.author.externalMACHADO, Luiz Fernando A.:Univ Fed Para, Inst Ciencias Biol, BR-66077830 Belem, PA, Brazil
hcfmusp.author.externalMARTINS, Luisa C.:Univ Fed Para, Nucleo Med Trop, BR-66055240 Belem, PA, Brazil
hcfmusp.author.externalSILVA-OLIVEIRA, Glaucia C.:Univ Fed Para, Inst Estudos Costeiros, BR-68600000 Braganca, PA, Brazil
hcfmusp.author.externalKUPEK, Emil:Univ Fed Santa Catarina, Programa Posgrad Saude Colet, BR-88040900 Florianopolis, SC, Brazil; Univ Fed Santa Catarina, Dept Saude Publ, BR-88040900 Florianopolis, SC, Brazil
hcfmusp.author.externalLEMOS, Jose Alexandre R.:Univ Fed Para, Inst Ciencias Biol, BR-66077830 Belem, PA, Brazil; Ctr Hematol & Hemoterapia Para, Lab Biol Mol, BR-66033000 Belem, PA, Brazil
hcfmusp.description.articlenumber236
hcfmusp.description.issue4
hcfmusp.description.volume8
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000506652300079
hcfmusp.origem.id2-s2.0-85075069677
hcfmusp.publisher.cityBASELeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceCaetano KAA, 2013, AIDS PATIENT CARE ST, V27, P1, DOI 10.1089/apc.2012.0268eng
hcfmusp.relation.referenceAnisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453eng
hcfmusp.relation.referenceAnteneh ZA, 2017, HIV AIDS-RES PALLIAT, V9, P43, DOI 10.2147/HIV.S127319eng
hcfmusp.relation.referenceAquino Priscila de Souza, 2008, Texto contexto - enferm., V17, P427, DOI 10.1590/S0104-07072008000300003eng
hcfmusp.relation.referenceAsselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027eng
hcfmusp.relation.referencePacheco SDB, 2014, REV SOC BRAS MED TRO, V47, P367, DOI 10.1590/0037-8682-0153-2013eng
hcfmusp.relation.referenceBarua P, 2012, INDIAN J MED RES, V136, P30eng
hcfmusp.relation.referenceBoettiger DC, 2020, CLIN INFECT DIS, V70, P106, DOI 10.1093/cid/ciz164eng
hcfmusp.relation.referenceCarter W, 2017, J CLIN PHARMACOL, V57, P287, DOI 10.1002/jcph.830eng
hcfmusp.relation.referenceCavalcante ND, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0064-2018eng
hcfmusp.relation.referencede Almeida MKC, 2012, J MED VIROL, V84, P1907, DOI 10.1002/jmv.23356eng
hcfmusp.relation.referenceCurry S, 2008, J VIROL METHODS, V153, P156, DOI 10.1016/j.jviromet.2008.07.020eng
hcfmusp.relation.referencede Aguiar SA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2859-xeng
hcfmusp.relation.referenceLobato CMD, 2019, ANN HEPATOL, V18, P849, DOI 10.1016/j.aohep.2019.08.001eng
hcfmusp.relation.referencede Oliveira AB, 2010, CAD SAUDE PUBLICA, V26, P837, DOI 10.1590/S0102-311X2010000400025eng
hcfmusp.relation.referencedos Santos LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207853eng
hcfmusp.relation.referenceENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8eng
hcfmusp.relation.referenceFerreira OD, 2018, MEDICINE, V97, pS3, DOI 10.1097/MD.0000000000009218eng
hcfmusp.relation.referencede Oliveira CSF, 2011, REV SOC BRAS MED TRO, V44, P546, DOI 10.1590/S0037-86822011000500003eng
hcfmusp.relation.referenceFrade P.C.R., 2019, PUBLIC HLTH COLLECTI, V4, P214, DOI [10.22533/at.ed.98319020922, DOI 10.22533/AT.ED.98319020922]eng
hcfmusp.relation.referenceFrade PCR, 2019, INT J STD AIDS, V30, P902, DOI 10.1177/0956462419849252eng
hcfmusp.relation.referenceGhosn J, 2008, AIDS, V22, P658, DOI 10.1097/QAD.0b013e3282f4e86feng
hcfmusp.relation.referenceGrgic I, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.45543eng
hcfmusp.relation.referenceGuindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010eng
hcfmusp.relation.referenceHalfon P, 2001, J CLIN MICROBIOL, V39, P1204, DOI 10.1128/JCM.39.3.1204-1206.2001eng
hcfmusp.relation.referenceHoffmann L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-57eng
hcfmusp.relation.referenceHuang W, 2019, MICROB DRUG RESIST, V25, P944, DOI 10.1089/mdr.2018.0360eng
hcfmusp.relation.referenceIshizaki A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179616eng
hcfmusp.relation.referenceJacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912eng
hcfmusp.relation.referenceJensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829eng
hcfmusp.relation.referenceKazerooni PA, 2014, INT J STD AIDS, V25, P155, DOI 10.1177/0956462413496227eng
hcfmusp.relation.referenceLampe E, 2013, ANTIVIR THER, V18, P435, DOI 10.3851/IMP2606eng
hcfmusp.relation.referenceLampe E, 2010, INFECT GENET EVOL, V10, P886, DOI 10.1016/j.meegid.2010.05.010eng
hcfmusp.relation.referenceLanini S, 2016, CLIN MICROBIOL INFEC, V22, P833, DOI 10.1016/j.cmi.2016.07.035eng
hcfmusp.relation.referenceLarsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531eng
hcfmusp.relation.referenceLefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149eng
hcfmusp.relation.referenceLeruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1eng
hcfmusp.relation.referenceLi Z, 2017, INFECT DRUG RESIST, V10, P377, DOI 10.2147/IDR.S146595eng
hcfmusp.relation.referenceLockart I, 2019, CURR OPIN INFECT DIS, V32, P31, DOI [10.1097/QCO.0000000000000515, 10.1097/qco.0000000000000515]eng
hcfmusp.relation.referenceManavi H, 1999, J INFECTION, V38, P60, DOI 10.1016/S0163-4453(99)90038-5eng
hcfmusp.relation.referenceMarx MA, 2003, CLIN INFECT DIS, V37, P514, DOI 10.1086/376639eng
hcfmusp.relation.referenceMason LMK, 2019, EUROSURVEILLANCE, V24, P5, DOI 10.2807/1560-7917.ES.2019.24.30.1800614eng
hcfmusp.relation.referenceMinistry of Health Brazil, 2018, B EP HEP VIReng
hcfmusp.relation.referencePuga MAM, 2018, REV SOC BRAS MED TRO, V51, P198, DOI 10.1590/0037-8682-0231-2017eng
hcfmusp.relation.referenceNguyen T., 2016, THESISeng
hcfmusp.relation.referenceNijmeijer BM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25348eng
hcfmusp.relation.referenceNishiya AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086413eng
hcfmusp.relation.referenceNyamathi Adeline, 2002, Biol Res Nurs, V4, P22, DOI 10.1177/1099800402004001004eng
hcfmusp.relation.referenceOliveira AB, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4270-2eng
hcfmusp.relation.referenceOliveira AB, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-38eng
hcfmusp.relation.referenceOliveira AB, 2010, MEM I OSWALDO CRUZ, V105, P103, DOI 10.1590/S0074-02762010000100016eng
hcfmusp.relation.referencePenha Jardeliny Corrêa da, 2015, Rev. Gaúcha Enferm., V36, P63, DOI 10.1590/1983-1447.2015.02.52089eng
hcfmusp.relation.referencePeres-da-Silva A, 2010, ARCH VIROL, V155, P807, DOI 10.1007/s00705-010-0642-zeng
hcfmusp.relation.referencePetruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824eng
hcfmusp.relation.referencePoordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494eng
hcfmusp.relation.referencePrati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003eng
hcfmusp.relation.referencede Freitas MDR, 2013, J MED VIROL, V85, P1741, DOI 10.1002/jmv.23654eng
hcfmusp.relation.referenceSarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037eng
hcfmusp.relation.referenceSarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041eng
hcfmusp.relation.referenceSawada L, 2011, REV SOC BRAS MED TRO, V44eng
hcfmusp.relation.referenceSilva FQ, 2018, ARCH VIROL, V163, P617, DOI 10.1007/s00705-017-3656-yeng
hcfmusp.relation.referenceSoares Manoel C. P., 1994, Boletin de la Oficina Sanitaria Panamericana, V117, P124eng
hcfmusp.relation.referenceSouza JC, 2019, TRANSFUSION, V59, P629, DOI 10.1111/trf.15045eng
hcfmusp.relation.referenceSucci R C, 1998, J Pediatr (Rio J), V74, P325eng
hcfmusp.relation.referenceSusser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192eng
hcfmusp.relation.referenceTe Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009eng
hcfmusp.relation.referenceTohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808eng
hcfmusp.relation.referenceTrickey A, 2019, LANCET GASTROENTEROL, V4, P435, DOI 10.1016/S2468-1253(19)30085-8eng
hcfmusp.relation.referenceValois RC, 2014, REV INST MED TROP SP, V56, P511, DOI 10.1590/S0036-46652014000600010eng
hcfmusp.relation.referencede Carvalho-Mello IMVG, 2010, J GEN VIROL, V91, P691, DOI 10.1099/vir.0.015594-0eng
hcfmusp.relation.referenceWang GP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21303-2eng
hcfmusp.relation.referenceWestbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012eng
hcfmusp.relation.referenceWong WCW, 2011, J TRAVEL MED, V18, P1, DOI 10.1111/j.1708-8305.2010.00453.xeng
hcfmusp.relation.referenceZeminian LB, 2013, MEM I OSWALDO CRUZ, V108, P13, DOI 10.1590/S0074-02762013000100002eng
dc.description.indexPubMedeng
dc.identifier.eissn2076-0817
hcfmusp.citation.scopus7-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Artigos e Materiais de Revistas Científicas - LIM/03
LIM/03 - Laboratório de Medicina Laboratorial

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_OLIVEIRA-FILHO_Hepatitis_C_Virus_among_Female_Sex_Workers_A_2019.PDFpublishedVersion (English)755.49 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.